Position in ARVN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$398,181
+$285,408 QoQ
Shares Held
47,916
+350.4% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#88
of 201 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names. ARVN ranks #31 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
59,477 | $2,015,675 | |
| 2 | RPRX |
Royalty Pharma plc
|
24,094 | $1,350,950 | |
| 3 | IMVT |
Immunovant, Inc.
|
34,827 | $1,341,884 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,726 | $1,260,518 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
28,315 | $1,104,568 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
38,178 | $1,001,027 | |
| 7 | EXEL |
Exelixis, Inc.
|
18,255 | $993,254 | |
| 8 | EYPT |
EyePoint, Inc.
|
58,528 | $836,950 |
All Filings in ARVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,181 | 47,916 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $112,773 | 10,639 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $974,026 | 82,127 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $504,162 | 59,174 | Shares | Sole | 2025-11-12 | |
| 2024-03-31 | $379,693 | 9,198 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $442,840 | 10,759 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||